SCHEMBL1301928

SCHEMBL1301928

CCC(O)CCCCCCCCCCCCC(=O)O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 3/20 0.74
FFAR1 O14842 3/20 0.74
ALDH1A1 P00352 3/20 0.55
GPR84 Q9NQS5 7/20 0.54
PPARG P37231 7/20 0.54
PPARD Q03181 7/20 0.54
PPARA Q07869 7/20 0.54
HDAC11 Q96DB2 5/20 0.54
TSHR P16473 4/20 0.54
PTPN1 P18031 3/20 0.54
TLR2 O60603 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
FABP4 P15090 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
MEN1 O00255 1/20 0.54
ESR1 P03372 1/20 0.54
ALOX15 P16050 1/20 0.54
PDE4A P27815 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1879331 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL16230477 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL710625 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL2493087 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL9633164 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1881578 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL974964 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL16230523 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1877352 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1877955 1.00 FFAR4 (0.74) FFAR4FFAR1ALDH1A1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4251276-A AND TRANSFER RIBBON LIQUID PAPER CORPORATION (US) 1981-02-17 US claimed
US-4027345-A Transfer printing TOYO BOSEKI KABUSHIKI KAISHA (JA) 1977-06-07 US claimed
JP-62098365-A None JP disclosed
US-12595495-B2 Methods of producing omega-hydroxylated fatty acid derivatives GENOMATICA, INC. (US) 2026-04-07 US disclosed
US-20260062720-A1 Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof AGAIN BIO APS (DK) 2026-03-05 US disclosed
EP-4150103-B1 METHOD FOR MANUFACTURING HYDROXY FATTY ACID-BASED POLYOLS U WINDMOELLER INNOVATION GMBH & CO KG (DE) 2025-04-09 EP disclosed
US-20250019731-A1 Methods Of Producing Omega-Hydroxylated Fatty Acid Derivatives AGAIN BIO APS (DK) 2025-01-16 US disclosed
US-20240309405-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF OXFORD FINANCE LLC 2024-09-19 US disclosed
CN-118460487-A Process for producing OMEGA-hydroxylated fatty acid derivatives 基因组股份公司 2024-08-09 CN disclosed
CN-118374462-A Process for producing OMEGA-hydroxylated fatty acid derivatives 基因组股份公司 2024-07-23 CN disclosed
US-11981952-B2 Methods of producing omega-hydroxylated fatty acid derivatives GENOMATICA, INC. (US) 2024-05-14 US disclosed
US-5430090-A Saponified polyvinyl acetate, hydroxy fatty acid, plasticizer NIPPON GOHSEI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1995-07-04 US disclosed
US-5284681-A Bringing into contact with water, drying in air SUMITOMO CHEMICAL CO., LTD. (JP) 1994-02-08 US disclosed
US-5214049-A Blend of polyphenylene ether, thermoplastic polyester and a hydroxycarboxylic acid or derivative; workability; solvent resistance; mechanical properties SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-05-25 US disclosed
EP-0456259-A1 Thermoplastic resin composition and article comprising the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-11-13 EP disclosed
EP-0368283-A2 Resin composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-05-16 EP disclosed
JP-S6298365-A LIQUID DEVELOPER FOR ELECTROSTATIC PHOTOGRAPHY RICOH CO LTD 1987-05-07 JP disclosed
US-4514287-A MIXING WITH ALUMINUM SULFATE NIPPON OIL CO., LTD. (JP) 1985-04-30 US disclosed
US-4251276-A AND TRANSFER RIBBON LIQUID PAPER CORPORATION (US) 1981-02-17 US disclosed
US-4027345-A Transfer printing TOYO BOSEKI KABUSHIKI KAISHA (JA) 1977-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062720-A1 Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof FASN, FFAR1, FFAR3 FFAR4 18/4885FFAR1 2/4885ALDH1A1 398/4885
US-12595495-B2 Methods of producing omega-hydroxylated fatty acid derivatives CYP4F11, CYP2F1, CYP4Z1 FFAR4 95/4885FFAR1 112/4885ALDH1A1 327/4885
US-20240309405-A1 MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF DGAT2, DGAT1, FASN FFAR4 76/4885FFAR1 31/4885ALDH1A1 1172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.